Laryngeal leishmaniasis

A patient suffering from persistent hoarseness was eventually shown to have laryngeal leishmaniasis. The incubation period for the disease must have been at least 16 years, following infection in Southern Europe. Mucosal leishmaniasis is rare in the Eastern hemisphere, and laryngeal leishmaniasis ha...

Full description

Saved in:
Bibliographic Details
Published in:Journal of laryngology and otology 1994-12, Vol.108 (12), p.1086-1088
Main Authors: Grant, Alison, Spraggs, P. D. R., Grant, H. R., Bryceson, A. D. M.
Format: Article
Language:English
Subjects:
Amphotericin B
Amphotericin B - therapeutic use
Animals
Biological and medical sciences
Clinical Records
Female
Human protozoal diseases
Humans
Infectious diseases
Laryngeal Diseases - drug therapy
Laryngeal Diseases - parasitology
Laryngeal Diseases - pathology
Larynx
Larynx - parasitology
Leishmaniasis
Leishmaniasis - drug therapy
Leishmaniasis - parasitology
Leishmaniasis - pathology
Leshmaniasis
Medical sciences
Middle Aged
Mucous Membrane - parasitology
Parasitic diseases
Protozoal diseases
Time Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A patient suffering from persistent hoarseness was eventually shown to have laryngeal leishmaniasis. The incubation period for the disease must have been at least 16 years, following infection in Southern Europe. Mucosal leishmaniasis is rare in the Eastern hemisphere, and laryngeal leishmaniasis has not previously been reported in the UK. Previous Mediterranean cases have run a similar chronic course and have caused diagnostic difficulty, in particular being mistaken for malignancy. Treatment with aminosidine was ineffective, but the patient responded to liposomal amphotericin.
ISSN:0022-2151
1748-5460
DOI:10.1017/S0022215100128968